Nuformix plc (LON:NFX – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 0.05 ($0.00) and last traded at GBX 0.06 ($0.00), with a volume of 49190609 shares changing hands. The stock had previously closed at GBX 0.06 ($0.00).
Nuformix Price Performance
The firm’s 50-day moving average price is GBX 0.17 and its 200-day moving average price is GBX 0.18. The company has a current ratio of 1.12, a quick ratio of 3.35 and a debt-to-equity ratio of 1.17. The stock has a market capitalization of £499,779.10, a PE ratio of -1.63 and a beta of 1.22.
Nuformix Company Profile
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Featured Stories
- Five stocks we like better than Nuformix
- 3 REITs to Buy and Hold for the Long Term
- The Average 401k Balance by Age Explained
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- What is a Stock Market Index and How Do You Use Them?
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
